T 0979/23 (Dravet syndrome II/KATHOLIEKE UNIVERSITEIT LEUVEN) of 01.10.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T097923.20241001
- Date of decision
- 1 October 2024
- Case number
- T 0979/23
- Petition for review of
- -
- Application number
- 18152406.7
- IPC class
- A61P 25/08A61K 31/137
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Fenfluramine for use in the treatment of Dravet syndrome
- Applicant name
- Katholieke Universiteit Leuven
University Hospital Antwerp - Opponent name
- Kraus & Lederer PartGmbB
Teva Pharmaceutical Industries, Ltd. - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(b)Rules of procedure of the Boards of Appeal Art 13(2)
- Keywords
- Late-filed document - justification for late filing (no)
Sufficiency of disclosure - (no) - Catchword
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.